VPC-80051 racemate
≥98%
- Product Code: 106719
CAS:
877969-69-2
| Molecular Weight: | 301.29 g./mol | Molecular Formula: | C₁₆H₁₃F₂N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
VPC-80051 racemate is primarily utilized in the field of medical research, particularly in the study of neurological disorders. Its application is focused on understanding and modulating specific pathways in the brain that are associated with conditions such as epilepsy, anxiety, and chronic pain. Researchers employ this compound to investigate its potential as a therapeutic agent, aiming to develop treatments that can effectively target and alleviate symptoms of these disorders. Additionally, VPC-80051 racemate is used in pharmacological studies to explore its interaction with various receptors and enzymes, providing insights into its mechanism of action and potential side effects. This research contributes to the broader goal of advancing drug development and improving patient outcomes in neurology.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | Ft193,933.94 |
+
-
|
| 0.010 | 10-20 days | Ft329,687.70 |
+
-
|
| 0.025 | 10-20 days | Ft698,162.20 |
+
-
|
VPC-80051 racemate
VPC-80051 racemate is primarily utilized in the field of medical research, particularly in the study of neurological disorders. Its application is focused on understanding and modulating specific pathways in the brain that are associated with conditions such as epilepsy, anxiety, and chronic pain. Researchers employ this compound to investigate its potential as a therapeutic agent, aiming to develop treatments that can effectively target and alleviate symptoms of these disorders. Additionally, VPC-80051 racemate is used in pharmacological studies to explore its interaction with various receptors and enzymes, providing insights into its mechanism of action and potential side effects. This research contributes to the broader goal of advancing drug development and improving patient outcomes in neurology.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :